{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:45:11Z","timestamp":1790027111178,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008623","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:00:00Z","timestamp":1388102400000}}],"reference-count":62,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008623.pub2","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T09:06:40Z","timestamp":1388135200000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis"],"prefix":"10.1002","volume":"2013","author":[{"given":"Layli","family":"Eslami","sequence":"first","affiliation":[{"name":"Golestan University of Medical Science, Taleghani Hospital; North Khayyam crossroad East Taleghani Avenue Gonbad e Kavous Golestan province Iran 49791-31983"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Merat","sequence":"additional","affiliation":[{"name":"Shariati Hospital, Tehran University of Medical Sciences; Digestive Diseases Research Centre; North Kargar Street Tehran Tehran Iran 14117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[{"name":"Shariati Hospital, Tehran University of Medical Sciences; Digestive Diseases Research Centre; North Kargar Street Tehran Tehran Iran 14117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Nasseri-Moghaddam","sequence":"additional","affiliation":[{"name":"Shariati Hospital, Tehran University of Medical Sciences; Digestive Diseases Research Centre; North Kargar Street Tehran Tehran Iran 14117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermineh","family":"Aramin","sequence":"additional","affiliation":[{"name":"Shariati Hospital, Tehran University of Medical Sciences; Digestive Diseases Research Centre; North Kargar Street Tehran Tehran Iran 14117"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,27]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD008623.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1185\/030079906X104696","article-title":"Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study","volume":"22","author":"Athyros","year":"2006","journal-title":"Current Medical Research and Opinion"},{"issue":"10","key":"10.1002\/14651858.CD008623.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/MCG.0b013e31819c392e","article-title":"A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomised placebo controlled trial","volume":"43","author":"Nelson","year":"2009","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2005.08.021","article-title":"Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidaemic patients","volume":"184","author":"Antonopoulos","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S1590-8658(12)60071-1","article-title":"Effect of statin therapy vs diet in hypercholesterolaemia patients affected by nonalcoholic steatohepatitis (NASH)","volume":"44S","author":"Carnelutti","year":"2012","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2036.2006.02926.x","article-title":"A pilot study of atorvastatin treatment in dyslipemic, non-alcoholic fatty liver patients","volume":"23","author":"Gomez-Dominguez","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacl.2012.01.009","article-title":"Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage)","volume":"6","author":"Han","year":"2012","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0008|cit8","first-page":"544","article-title":"Atorvastatin for the treatment of NASH","volume":"120A","author":"Harlander","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0009|cit9","first-page":"131","article-title":"Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidaemia","volume":"23","author":"Hatzitolios","year":"2004","journal-title":"Indian Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD008623.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1155\/2003\/857869","article-title":"Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis","volume":"17","author":"Kiyici","year":"2003","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008623.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","article-title":"Efficacy and safety of high-dose pravastatin in hypercholesteraemic patients with well compensated chronic liver disease: results of a prospective, randomised, double blind, placebo-controlled, multicenter trial","volume":"46","author":"Lewis","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2004.01.008","article-title":"Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study","volume":"174","author":"Rallidis","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0013|cit13","first-page":"28","article-title":"Simvastatin in treatment of non-alcoholic steatohepatitis: a clinical trial","volume":"14","author":"Tavakkoli","year":"2009","journal-title":"Govaresh"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1592\u2013609","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008623.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/00365520500320060","article-title":"Rosuvastatin: a safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Ahmed","year":"2006","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.metabol.2005.03.010","article-title":"Targeting vascular risk in patients with metabolic syndrome but without diabetes","volume":"54","author":"Athyros","year":"2005","journal-title":"Metabolism"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.163.5.553","article-title":"Risk for myopathy with statin therapy in high-risk patients","volume":"163","author":"Ballantyne","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008623.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.semdp.2006.04.002","article-title":"NASH: pathologic features and differential diagnosis","volume":"22","author":"Brunt","year":"2005","journal-title":"Seminars in Diagnostic Pathology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/modpathol.3800680","article-title":"Pathology of fatty liver disease","volume":"20 Suppl 1","author":"Brunt","year":"2007","journal-title":"Modern Pathology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0023|cit23","first-page":"1428","article-title":"The liver in systemic conditions","volume-title":"Hepatology","author":"Cello","year":"1990"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0028-1091979","article-title":"Abnormalities of lipid metabolism in nonalcoholic fatty liver disease","volume":"28","author":"Cheung","year":"2008","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0026|cit26","first-page":"322","article-title":"Alcoholic hepatitis: no glucocorticosteroids?","volume-title":"Steatohepatitis (NASH and ASH) - Falk Symposium 121","author":"Gluud","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0028|cit28","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2013, Issue 11. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0029|cit29","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD008623.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/j.1440-1746.2006.04698.x","article-title":"Significant correlations between severe fatty liver and risk factors for\u00a0metabolic syndrome","volume":"22","author":"Hsiao","year":"2007","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0031|cit31","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.9734\/BJMMR\/2013\/3208","article-title":"The necessity of randomized clinical trials","volume":"3","author":"Jakobsen","year":"2013","journal-title":"British Journal of Medicine and Medical Research"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","article-title":"Risks associated with statin therapy: a systematic overview of randomized clinical trials","volume":"114","author":"Kashani","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD008623.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0046-8177(89)90249-9","article-title":"Nonalcoholic steatohepatitis: a study of 49 patients","volume":"20","author":"Lee","year":"1989","journal-title":"Human Pathology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.pu.12.050191.000353","article-title":"Words without action? The production, dissemination, and impact of consensus recommendations","volume":"12","author":"Lomas","year":"1991","journal-title":"Annual Review of Public Health"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clinic Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD008623.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9128","key":"10.1002\/14651858.CD008623.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Executive summary of the third report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001 2486 97","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/abbi.1996.0030","article-title":"Inhibitors of cholesterol biosynthesis increase hepatic low density lipoprotein receptor protein degradation","volume":"325","author":"Ness","year":"1996","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1572-0241.2007.01520.x","article-title":"Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD)","volume":"102","author":"Poonam\u00a0M","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008623.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidemic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0887-2171(95)90012-8","article-title":"CT and MRI of diffuse liver disease","volume":"16","author":"Rofsky","year":"1995","journal-title":"Seminars in Ultrasound, CT, and MR"},{"issue":"4","key":"10.1002\/14651858.CD008623.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008623.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"35","key":"10.1002\/14651858.CD008623.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD008623.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008623.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD008623.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD008623.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004816.pub5","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"28J","DOI":"10.1016\/0002-9149(88)90004-5","article-title":"Efficacy and long-term adverse effect pattern of lovastatin","volume":"62","author":"Tobert","year":"1988","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD008623.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006870.pub2","article-title":"Statins for acute coronary syndrome","author":"Vale","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.22980","article-title":"Specific role for acyl CoA: Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids","volume":"50","author":"Villanueva","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008623.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD008623.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00644.2005","article-title":"Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells","volume":"291","author":"Wei","year":"2006","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008623.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/RTPM1PY6YGBL2G2R","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"128","author":"Yeh","year":"2007","journal-title":"American Journal of Clinical Pathology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008623.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:03:42Z","timestamp":1746389022000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008623.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008623.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}